606 related articles for article (PubMed ID: 25696997)
1. [Peptide 612-627 of thyrotropin receptor and its modified derivatives as the regulators of adenylyl cyclase in the rat thyroid gland].
Shpakov AO; Shpakova EA; Tarasenko II; Derkach KV
Tsitologiia; 2014; 56(7):526-35. PubMed ID: 25696997
[TBL] [Abstract][Full Text] [Related]
2. [Regulation of adenylyl cyclase activity in the rat testes by acylated derivatives of peptide 562-572 of luteinizing hormone receptor].
Shpakova EA; Shpakov AO
Tsitologiia; 2013; 55(10):737-44. PubMed ID: 25509128
[TBL] [Abstract][Full Text] [Related]
3. [N-palmitoylated peptide 232-245 of rat type 4 melanocortin receptor possessing agonistic activity].
Shpakov AO; Shpakova EA; Tarasenko II; Derkach KV
Tsitologiia; 2014; 56(8):604-11. PubMed ID: 25697006
[TBL] [Abstract][Full Text] [Related]
4. [The secondary structure of peptides derived from the third intracellular loop of the serpentine type receptors and its interrelation with their biological activity].
Shpakova EA; Skvortsova EA; Tarasenko II; Shpakov AO
Tsitologiia; 2012; 54(2):119-29. PubMed ID: 22590924
[TBL] [Abstract][Full Text] [Related]
5. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
[TBL] [Abstract][Full Text] [Related]
6. 1,25-Dihydroxyvitamin D3 attenuates adenylyl cyclase activity in rat thyroid cells: reduction of thyrotropin receptor number and increase in guanine nucleotide-binding protein Gi-2 alpha.
Berg JP; Sandvik JA; Ree AH; Sørnes G; Bjøro T; Torjesen PA; Gordeladze JO; Haug E
Endocrinology; 1994 Aug; 135(2):595-602. PubMed ID: 8033808
[TBL] [Abstract][Full Text] [Related]
7. [Comparative study of molecular mechanisms of natural and synthetic polycationic peptides action on the activity of the adenylyl cyclase signaling system].
Shpakov AO; Gur'ianov IA; Kuznetsova LA; Plesneva SA; Zakharova ET; Vlasov GP; Pertseva MN
Tsitologiia; 2006; 48(5):450-9. PubMed ID: 16892855
[TBL] [Abstract][Full Text] [Related]
8. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
[TBL] [Abstract][Full Text] [Related]
9. Cloning of the single strand DNA-binding protein important for maximal expression and thyrotropin (TSH)-induced negative regulation of the TSH receptor.
Ohmori M; Ohta M; Shimura H; Shimurat Y; Suzuki K; Kohn LD
Mol Endocrinol; 1996 Nov; 10(11):1407-24. PubMed ID: 8923467
[TBL] [Abstract][Full Text] [Related]
10. Dual mechanism of perturbation of thyrotropin-mediated activation of thyroid cells by antibodies to the thyrotropin receptor (TSHR) and TSHR-derived peptides.
Desai RK; Dallas JS; Gupta MK; Seetharamaiah GS; Fan JL; Tahara K; Kohn LD; Prabhakar BS
J Clin Endocrinol Metab; 1993 Sep; 77(3):658-63. PubMed ID: 8103771
[TBL] [Abstract][Full Text] [Related]
11. Evidence that partially desialylated variants of human chorionic gonadotropin (hCG) are the factors in crude hCG that inhibit the response to thyrotropin in human thyroid membranes.
Hoermann R; Amir SM; Ingbar SH
Endocrinology; 1988 Sep; 123(3):1535-43. PubMed ID: 3402396
[TBL] [Abstract][Full Text] [Related]
12. Carbachol-induced decrease in thyroid cell adenylyl cyclase activity is independent of calcium and phosphodiesterase activation.
Pasquali D; Rani CS; Deery WJ
Mol Pharmacol; 1992 Jan; 41(1):163-7. PubMed ID: 1310140
[TBL] [Abstract][Full Text] [Related]
13. TSH binding correlates with TSH-stimulated thyroid adenylate cyclase activity in human thyroid tissues.
Duh QY; Siperstein AE; Miller RA; Smeds S; Clark OH
Surgery; 1989 Dec; 106(6):967-73; discussion 973-4. PubMed ID: 2588124
[TBL] [Abstract][Full Text] [Related]
14. The intracellular region adjacent to plasma membrane (residues 684-692) of the thyrotropin receptor is important for phosphoinositide signaling but not for agonist-induced adenylate cyclase activation.
Kosugi S; Mori T
Biochem Biophys Res Commun; 1994 Mar; 199(3):1497-503. PubMed ID: 8147896
[TBL] [Abstract][Full Text] [Related]
15. Severe but not mild alterations of thyroid function modulate the density of thyroid-stimulating hormone receptors in the rat thyroid gland.
Denereaz N; Lemarchand-Beraud T
Endocrinology; 1995 Apr; 136(4):1694-700. PubMed ID: 7895680
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the thyrotropin receptor-adenylate cyclase system in neoplastic human thyroid tissue.
Clark OH; Gerend PL; Goretzki P; Nissenson RA
J Clin Endocrinol Metab; 1983 Jul; 57(1):140-7. PubMed ID: 6304132
[TBL] [Abstract][Full Text] [Related]
17. Amiodarone effects on thyrotropin receptors and responses stimulated by thyrotropin and carbachol in cultured dog thyroid cells.
Rani CS
Endocrinology; 1990 Dec; 127(6):2930-7. PubMed ID: 2174339
[TBL] [Abstract][Full Text] [Related]
18. Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships.
Szkudlinski MW; Fremont V; Ronin C; Weintraub BD
Physiol Rev; 2002 Apr; 82(2):473-502. PubMed ID: 11917095
[TBL] [Abstract][Full Text] [Related]
19. Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor.
Kosugi S; Ban T; Kohn LD
Mol Endocrinol; 1993 Jan; 7(1):114-30. PubMed ID: 8095322
[TBL] [Abstract][Full Text] [Related]
20. Thyrotropin regulation of adenylate cyclase activity in human thyroid neoplasms.
Clark OH; Gerend PL
Surgery; 1985 May; 97(5):539-46. PubMed ID: 2986305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
